Branded approval status There is no FDA-approved branded BPC-157 product
The active cation (C 10 H 11 N 2 + ) consists of a methylated quinolinium ring bearing a 5-amino substituent
M., Fourrier, C., Bensalem, J
Multiple preclinical studies have investigated BPC-157 in crush injury and transection muscle models, examining myocyte repair kinetics, satellite cell activity, and functional recovery metrics in controlled laboratory settings
In addition, we extracted and analyzed the tissue nuclear and cytoplasmic -catenin protein expression (Fig
Common Side Effects Mild pain or redness at the injection site Temporary dizziness Serious Side Effects Allergic reaction (rare) Swelling or breathing difficulty Serious reactions are uncommon, but you should seek medical help if symptoms worsen